Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation

Liver International

Volumn 34, Issue 5, 2014, Pages 672-678

  Habib, Mohamed ^a   Roberts, Lara N ^a   Patel, Raj K ^a   Wendon, Julia ^b   Bernal, William ^b   Arya, Roopen ^a  

^a King's Thrombosis Centre   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute liver failure; Acute liver injury; Coagulation; Thrombin generation

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; PARACETAMOL; PROTEIN C; THROMBIN; THROMBOMODULIN; F8 PROTEIN, HUMAN;

ACUTE DISEASE; ACUTE HEPATITIS; ACUTE LIVER FAILURE; ACUTE LIVER INJURY; ADULT; ARTICLE; BLOOD CLOTTING PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG OVERDOSE; ENDOGENOUS THROMBIN POTENTIAL; FEMALE; HEAT STROKE; HEMOSTASIS; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; INFECTIOUS COMPLICATION; KIDNEY FAILURE; LIVER HEMORRHAGE; LIVER INJURY; LIVER ISCHEMIA; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; RENAL REPLACEMENT THERAPY; THROMBIN TIME; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; NORMAL HUMAN; PATHOPHYSIOLOGY; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FACTOR VIII; FEMALE; HEALTHY VOLUNTEERS; HEMOSTASIS; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PROTEIN C; THROMBIN; THROMBOMODULIN; YOUNG ADULT;

EID: 84897941520     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12369     Document Type: Article

References (30)

1. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010; 116: 878-85.
2. Tripodi A, Chantarangkul V, Mannucci PM. Acquired coagulation disorders: revisiting using global coagulation/anticoagulation testing. Br J Haematol 2009; 147: 77-82.
3. Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981; 26: 388-93.
4. Auzinger G, O'Callaghan GP, Bernal W, Sizer E, Wendon J. Percutaneous tracheostomy in patients with severe liver disease and a high incidence of refractory coagulopathy: a prospective trial. Crit Care 2007; 11: R110.
5. Dargaud Y, Trzeciak MC, Bordet J-C, Ninet J, Negrier C. Use of calibrated automated thrombography ± thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost 2006; 96: 562-7.
6. Dargaud Y, Beguin S, Lienhart A, et al. Evaluation of thrombin generating capacity in plamsa from patients with haemophilia A and B. Thromb Haemost 2005; 93: 475-80.
7. Al Dieri R, Peyvandi F, Santagostino E, et al. The thrombogram in rare inherited coagulation disorders: Its relation to clinical bleeding. Thromb Haemost 2002; 88: 576-82.
8. Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal coagulation tests. Hepatology 2005; 41: 553-8.
9. Gatt A, Riddell A, Calvaruso V, et al. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost 2010; 8: 1994-2000.
10. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. The Lancet 1993; 342: 273-5.
11. Kerr R, Newsome P, Germian L, et al. Effects of acute liver injury on blood coagulation. J Thromb Haemost 2003; 1: 754-9.
12. Lisman T, Bakhtiari K, Adelmeijer J, et al. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost 2012; 10: 1312-9.
13. Agarwal B, Wright G, Gatt A, et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol 2012; 57: 780-6.
14. Bagot CN, Marsh MS, Whitehead M, et al. The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy. J Thromb Haemost 2010; 8: 1736-44.
15. Hemker HC, Giesen P. Al Dieri R, Regnault V, De Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
16. Roberts LN, Patel RK, Chitongo P, Bonner L, Arya R. African-Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation. Blood Coagul Fibrinolysis 2013; 24: 40-9.
17. Tripodi A, Primignani M, Chantarangkul V, et al. An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis. Gastroenterology 2009; 137: 2105-11.
18. Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of Factor V. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 1396-400.
19. Shen L, Dahlback B. Factor V and Protein S as synergistic cofactors to activated Protein C in degradatio of Factor VIIIa. The Journal of Biological Chemistry 1994; 269: 18735-8.
20. Dielis AWJH, Castoldi E, Spronk HMH, et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008; 6: 125-31.
21. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004; 2: 1954-9.
22. van Veen JJ, Gatt A, Cooper PC, et al. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagul Fibrinolysis 2008; 19: 183-9.
23. Haidl H, Cimenti C, Lecschnik B, Zach D, Muntean W. Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost 2006; 95: 772-25.
24. Stravitz RT, Lisman T, Luketic VA, et al. Minimal Effects of Acute Liver Injury/Acute Liver Failure on Hemostasis as Assessed by Thromboelastography. J Hepatol 2012; 56: 129-36.
25. Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007; 35: 2498-508.
26. Caldwell SH, Hoffman M, Lisman T, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006; 44: 1039-46.
27. Munoz SJ, Rajender Reddy K, Lee W, et al. The coagulopathy of acute liver failure and implications for intracranial pressure monitoring. Neurocrit Care 2008; 9: 103-7.
28. Massicotte L, Lenis S, Thibeault L, et al. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006; 12: 117-23.
29. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365: 147-56.
30. Van Veen JJ, Gatt A, Makris M. Thrombin generation in routine clinical practice: are we there yet? Br J Haematol 2008; 142: 889-903.